Adhesive capsulitis of shoulder. Adhesive capsulitis of shoulder
Conditions
Interventions
Intervention 1: After the diagnosis of frozen shoulder by the orthopedist in the clinic, the patients refer to the operating room for injection and are randomly divided into three groups. For injectio
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Definitive diagnosis of ice shoulder by an orthopedic doctor Failure to respond to non-invasive treatments such as physiotherapy and drug therapy Active and passive reduction of rom movements Age between 18-60 years
Exclusion criteria
Exclusion criteria: known systemic diseases such as rheumatoid arthritis History of recent trauma or surgery or known chronic disease (such as rotator cuff lesions) Pivacaine, any known systemic disease Midclavicular joint, cervical radiculopathy Brachial plexopathy, neoplasm pregnancy Addiction to opioids diabetes Osteoarthritis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score obtained on the Pittsburgh Sleep Quality Questionnaire. Timepoint: Before the injection and during the follow-up times 2-6-12-24 weeks after the intervention. Method of measurement: Pittsburgh Sleep Quality Index.;Visual Analogue Pain Scale. Timepoint: Before the injection and during the follow-up times 2-6-12-24 weeks after the intervention. Method of measurement: Score obtained on the visual analog scale.;Shoulder Internal Rotation Movement Scale score. Timepoint: Before the injection and during the follow-up times 2-6-12-24 weeks after the intervention. Method of measurement: Score obtained based on the goniometer device.;Shoulder external rotation movement scale score. Timepoint: Before the injection and during the follow-up times 2-6-12-24 weeks after the intervention. Method of measurement: Score obtained based on the goniometer device.;Shoulder abduction range of motion score. Timepoint: Before the injection and during the follow-up times 2-6-12-24 weeks after the intervention. Method of measurement: Score obtained based on the goniometer device.;Shoulder flexion movement scale. Timepoint: Before the injection and during the follow-up times 2-6-12-24 weeks after the intervention. Method of measurement: Score obtained based on the goniometer device.;Time to recovery. Timepoint: At follow-up times every week after the intervention. Method of measurement: Recovery of maximum shoulder ROM based on goniometry and absence of pain based on visual analog scale (VAS).;Score obtained on the Shoulder Pain and Disability Index. Timepoint: Before the injection and during the follow-up times 2-6-12-24 weeks after the intervention. Method of measurement: Shoulder Pain and Disability Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactyasin sharifzadeh
Babol University of Medical Sciences
Outcome results
None listed